These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1630554)

  • 21. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 22. Supravenous hyperpigmentation induced by vinorelbine.
    Cecchi R; Tuci F; Giomi A; Innocenti F
    Dermatology; 1994; 188(3):244. PubMed ID: 8186521
    [No Abstract]   [Full Text] [Related]  

  • 23. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.
    Romero A; Rabinovich MG; Vallejo CT; Perez JE; Rodriguez R; Cuevas MA; Machiavelli M; Lacava JA; Langhi M; Romero Acuña L
    J Clin Oncol; 1994 Feb; 12(2):336-41. PubMed ID: 8113840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Current Status of Vinorelbine (Navelbine) in Breast Cancer. Proceedings of a symposium. McLean, Virginia, April 28-May 1, 1994.
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):1-87. PubMed ID: 7740331
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary toxicity associated with vinorelbine-based chemotherapy in breast cancer.
    Yanagitani N; Shimizu Y; Kaira K; Tatsuno S; Sunaga N; Ishizuka T; Mori M
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1619-21. PubMed ID: 18799925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
    Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
    J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).
    Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):26-9. PubMed ID: 2540532
    [No Abstract]   [Full Text] [Related]  

  • 30. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of concurrent vinorelbine and radiation therapy in high-risk postmastectomy breast cancer patients.
    Honda K; Riku M; Iwase M; Hirasawa N; Yamada T; Goto Y; Kawada K
    Breast Cancer; 2016 Sep; 23(5):701-5. PubMed ID: 26206720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
    Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
    J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The study of cisplatin and vinorelbine in metastatic uterine cervical cancer.
    Kamnerdsupaphon P; Chitapanarux I; Tharavichitkul E; Sukthomya V; Lorvidhaya V
    J Med Assoc Thai; 2009 Jun; 92(6):836-40. PubMed ID: 19530590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
    Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
    Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 38. [Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989].
    Lhommé C
    Rev Prat; 1990 Sep; 40(19):1780-1. PubMed ID: 2171131
    [No Abstract]   [Full Text] [Related]  

  • 39. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vinorelbine promising and well tolerated in patients with advanced breast cancer.
    Oncology (Williston Park); 1997 Feb; 11(2):255. PubMed ID: 9057178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.